Mumbai-based healthcare-technology company running an integrated ecosystem of medical education, HCP market/clinical research, practice-enhancement tools and CRO/CRAMS contract-research services for healthcare professionals and pharma compa
Price
Market Cap
Sector
Consumer Discretionary
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 0 | 0 | 2 | 3 | 3 | 3 |
| Reserves | -0 | 0 | 1 | 1 | 7 | 5 | 5 |
| Borrowings | 0 | 1 | 5 | 8 | 9 | 7 | 7 |
| Other Liabilities | 2 | 4 | 4 | 5 | 11 | 24 | 22 |
| Total Liabilities | 2 | 6 | 10 | 17 | 30 | 39 | 38 |
| AssetsFixed Assets | 0 | 0 | 1 | 2 | 1 | 1 | 14 |
| CWIP | 0 | 0 | 0 | 0 | 9 | 12 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 2 | 5 | 8 | 14 | 19 | 25 | 23 |
| Total Assets | 2 | 6 | 10 | 17 | 30 | 39 | 38 |
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 0 | -0 | -2 | -1 | 5 | 7 |
| Cash from Investing | -0 | -0 | -2 | -2 | -8 | -4 |
| Cash from Financing | 0 | 1 | 3 | 3 | 6 | -4 |
| SummaryCapital Expenditure | — | — | — | — | — | — |
| Free Cash Flow | -0 | -1 | -2 | -2 | -3 | 3 |
| FCF Margin | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
DHTL · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.